Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation

Am J Respir Crit Care Med. 2016 Dec 15;194(12):1552-1555. doi: 10.1164/rccm.201606-1145LE.

Authors

David B Kantor^{1

2}, Molly C McDonald¹, Nicole Stenquist¹, Blake J Schultz¹, Craig D Smallwood¹, Kyle A Nelson^{1

2}, Wanda Phipatanakul^{1

2}, Joel N Hirschhorn^{1

2

3}

Affiliations

¹ 1 Boston Children's Hospital Boston, Massachusetts.
² 2 Harvard Medical School Boston, Massachusetts and.
³ 3 Broad Institute of Harvard and Massachusetts Institute of Technology Cambridge, Massachusetts.

No abstract available

Publication types

Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Adolescent
Anti-Asthmatic Agents / therapeutic use*
Asthma / drug therapy*
Child
Cohort Studies
Female
Humans
Male
Omalizumab / therapeutic use*
Prospective Studies
Rhinovirus*
Severity of Illness Index
Treatment Outcome

Substances

Anti-Asthmatic Agents
Omalizumab

Grants and funding